Phaseline

Companies › InnoUp Farma

InnoUp Farma: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 1; Other.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
INP20
Oral immunotherapy with peanut protein
–Phase 1Peanut Allergy–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT04163562INP20Phase 1Peanut AllergyOtherMay 2025

Targets

No annotated target.

Companies with the same targets

–

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.